ALLMedicine™ Cirrhosis Center
Research & Reviews 19,978 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037251
World Journal of Gastroenterology; Leowattana W, Leowattana T et. al.
Mar 28th, 2023 - Hepatocellular carcinoma (HCC) is most commonly found in the context of liver cirrhosis and, in rare cases, in a healthy liver. Its prevalence has risen in recent years, particularly in Western nations, due to the increasing frequency of non-alcoh...
https://doi.org/10.14309/ctg.0000000000000585
Clinical and Translational Gastroenterology; McLean Diaz P, Vannier A et. al.
Mar 28th, 2023 - We hypothesized that fibroblast growth factor-21 (FGF-21) would be highly expressed in patients with alcohol-associated hepatitis (AH) and could be a novel and biologically relevant predictive biomarker to reliably distinguish severe AH and decomp...
https://doi.org/10.1097/LVT.0000000000000137
Liver Transplantation : Official Publication of the Ameri... Patel N, Silvey S et. al.
Mar 28th, 2023 - Guidelines recommend that all hospitalized patients with cirrhosis and ascites receive an early (<24 h from admission) paracentesis. However, national data are not available regarding compliance with and consequences of this quality metric. We uti...
https://doi.org/10.1097/MEG.0000000000002541
European Journal of Gastroenterology & Hepatology; Wang C, Gao H et. al.
Mar 27th, 2023 - Available data regarding cardiomyopathy in patients with alcoholic liver cirrhosis (ALC) are very limited because it often requires multidisciplinary assessments. The study aims to evaluate the prevalence of alcoholic cardiomyopathy in ALC and the...
https://doi.org/10.1097/MEG.0000000000002536
European Journal of Gastroenterology & Hepatology; Cui B, Hui Y et. al.
Mar 27th, 2023 - Dynapenia embraces clinical significance and predictive value separated from skeletal muscle loss among cirrhosis. Moreover, alterations in lipid levels may impact muscle function. It has yet to elucidate the relationship between lipid profiles an...
Guidelines 44 results
https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(22)00317-6/fulltext
The Lancet Public Health; Anderson BO, .
Jan 1st, 2023 - The overall risks and harms resulting from alcohol consumption have been systematically assessed and are well documented. According to the latest WHO estimates,1 alcohol consumption contributed to 3 million deaths in 2016 globally and was responsi...
https://doi.org/10.1016/j.cgh.2022.08.033
Clinical Gastroenterology and Hepatology : the Official C... Flamm SL, Wong F et. al.
Sep 9th, 2022 - The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update is to review the available published evidence and expert advice regarding the clinical management of patients with suspected acute kidney injury ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398982
Gastroenterology Long MT, Noureddin M et. al.
Jul 17th, 2022 - Nonalcoholic fatty liver disease (NAFLD) is well recognized as a leading etiology for chronic liver disease, affecting >25% of the US and global populations. Up to 1 in 4 individuals with NAFLD have nonalcoholic steatohepatitis, which is associate...
https://doi.org/10.1016/j.jhep.2022.03.033
Journal of Hepatology; ,
Jun 7th, 2022 - Haemochromatosis is characterised by elevated transferrin saturation (TSAT) and progressive iron loading that mainly affects the liver. Early diagnosis and treatment by phlebotomy can prevent cirrhosis, hepatocellular carcinoma, diabetes, arthropa...
https://doi.org/10.1016/j.eprac.2022.03.010
Endocrine Practice : Official Journal of the American Col... Cusi K, Isaacs S et. al.
May 16th, 2022 - To provide evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to endocrinologists, primary care clinicians, health care professionals, and other...
Drugs 874 results see all →
Clinicaltrials.gov 2,530 results
https://clinicaltrials.gov/ct2/show/NCT03520660
Mar 23rd, 2023 - Study Description:
https://clinicaltrials.gov/ct2/show/NCT03451292
Mar 23rd, 2023 - This is a phase 3, multicenter, randomized, controlled, parallel-group, and open-label clinical study to evaluate the efficacy of standard medical treatment (SMT) + Albutein 20% administration versus SMT alone in subjects with decompensated cirrho...
https://clinicaltrials.gov/ct2/show/NCT04581369
Mar 22nd, 2023 - In the Cirrhosis Medical Home, a care coordinator, supported by an interdisciplinary clinical team, will deliver a personalized intervention guided by a set of innovative tools: (i) patient-centered care protocols, (ii) a mobile office, (iii) care...
https://clinicaltrials.gov/ct2/show/NCT00326482
Mar 21st, 2023 - At present, there are no clear guidelines as to when antiretroviral therapy for human immunodeficiency virus (HIV) infection should be stopped in the setting of elevated liver enzymes. In large part, this is due to a limited understanding of the n...
https://clinicaltrials.gov/ct2/show/NCT05282121
Mar 21st, 2023 - This study is open to adults with liver cirrhosis caused by hepatitis B, hepatitis C or nonalcoholic steatohepatitis (NASH). People can join this study if they have high blood pressure in the portal vein (main vessel going to the liver). The purpo...
News 2,318 results
https://www.mdedge.com/chestphysician/article/261831/society-news/breathing-easier-growing-adoption-indwelling-pleural
Mar 15th, 2023 - Thoracic Oncology Network Interventional Procedures Section The management of recurrent pleural effusions is challenging. Indwelling tunneled pleural catheters (IPCs) have been shown to reduce the need for additional pleural procedures, admissions.
https://www.medpagetoday.com/infectiousdisease/hepatitis/103474
Mar 9th, 2023 - All adults should be tested for a hepatitis B virus (HBV) infection at least once in their lifetime, and a wider range should get periodic retesting, according to new CDC recommendations. The report recommended moving from a risk-based approach to...
https://www.mdedge.com/gihepnews/article/261682/liver-disease/earlier-hep-b-biomarker-clinical-outcomes
Jim Kling, MDedge News
Mar 8th, 2023 - Low serum levels of the hepatitis B core-related antigen (HBcrAg) could be an early biomarker of a functional cure of a hepatitis B infection, according to new findings from a retrospective study. A drop in HBcrAg predicted the seroclearance of he.
https://www.mdedge.com/hematology-oncology/article/260791/gastrointestinal-cancer/palliative-radiotherapy-successfully
Randy Dotinga
Jan 25th, 2023 - Most patients with end-stage hepatocellular carcinoma experience pain, but when it’s severe, how best to control the pain is debatable. A number of studies, including one recently presented at the ASCO Gastrointestinal Cancers Symposium 2023, show.
https://www.mdedge.com/internalmedicine/article/260714/geriatrics/geriatrician-advises-use-vitamin-d-supplementation
Mengru Wang, MD, MPH
Jan 20th, 2023 - This article discusses updates in geriatrics from studies published in 2022 to early 2023. The topics covered include vitamin D supplementation and incident fractures, the association of social isolation and dementia, and the release of lecanemab,.